Cardiovascular Outcomes Among Patients with COPD Prescribed with LABA or LAMA: A Real-World Territory Wide Study
Patients with COPD treated with LAMA might have higher incidence of atrial fibrillation when compared with LABA but not other cardiovascular events.
Authors
- Wang Chun Kwok (ORCID: https://orcid.org/0000-0002-5611-1637)
- Chung Ki Tsui
- Edward Y. Cheng (ORCID: https://orcid.org/0000-0001-6125-9671)
- Chun‐Ka Wong (ORCID: https://orcid.org/0000-0001-5205-9440)
- Hung‐Fat Tse (ORCID: https://orcid.org/0000-0002-9578-7808)
- Ting Fung (ORCID: https://orcid.org/0000-0001-6028-5640)
- Ali Choo
- James Chung Man Ho (ORCID: https://orcid.org/0000-0003-4499-5284)
- Albert Ko (ORCID: https://orcid.org/0009-0004-5939-1947)
Institutions
- University of South Carolina (US)
- Queen Mary Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1007/s12325-025-03375-5
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00